[Niflumic acid and otospongiosis].
D000814:Aniline Compounds / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003051:Cochlea / Q000187:drug effects; D005260:Female; D005461:Fluorine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010040:Otosclerosis / Q000601:surgery*; D011183:Postoperative Complications / Q000517:prevention & control; D013201:Stapes Surgery; D014724:Vestibular Function Tests
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D005461:Fluorine
Acide niflumique et otospongiose.